Literature DB >> 10984573

Protecting research subjects--what must be done.

D Shalala1.   

Abstract

Keywords:  Biomedical and Behavioral Research; Legal Approach

Mesh：

Year:  2000        PMID： 10984573     DOI： 10.1056/NEJM200009143431112

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

1.  Ethics behind closed doors: do research ethics committees need secrecy?

Authors:  R Ashcroft; N Pfeffer
Journal:  BMJ       Date:  2001-05-26

2.  [Psychiatrists and the pharmaceutical industry].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

Review 3.  Genetic information and research: emerging legal issues.

Authors:  Roberta M Berry
Journal:  HEC Forum       Date:  2003-03

Review 4.  Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies.

Authors:  Ellen Frank; Danielle M Novick; David J Kupfer
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

5.  Suspension of the NIH ARDS Network fluids and catheters treatment trial.

Authors:  François Lemaire
Journal:  Intensive Care Med       Date:  2003-07-15       Impact factor: 17.440

6.  Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators.

Authors:  Kevin P Weinfurt; Joëlle Y Friedman; Michaela A Dinan; Jennifer S Allsbrook; Mark A Hall; Jatinder K Dhillon; Jeremy Sugarman
Journal:  J Law Med Ethics       Date:  2006       Impact factor: 1.718

7.  Developing model language for disclosing financial interests to potential clinical research participants.

Authors:  Kevin P Weinfurt; Jennifer S Allsbrook; Joëlle Y Friedman; Michaela A Dinan; Mark A Hall; Kevin A Schulman; Jeremy Sugarman
Journal:  IRB       Date:  2007 Jan-Feb

Review 8.  Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Authors:  Claire T Deakin; Ian E Alexander; Ian Kerridge
Journal:  Mol Ther       Date:  2009-09-22       Impact factor: 11.454

Review 9.  Compliance in early-phase cancer clinical trials research.

Authors:  Razelle Kurzrock; David J Stewart
Journal:  Oncologist       Date:  2013-03-01

10.  Effects of disclosing financial interests on attitudes toward clinical research.

Authors:  Kevin P Weinfurt; Mark A Hall; Michaela A Dinan; Venita DePuy; Joëlle Y Friedman; Jennifer S Allsbrook; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.